Consumer Defensive · Equity Analysis

PepsiCo Inc. (PEP) Stock Analysis — Price Target, Hold Rating & DCF Valuation (2026)

By Anton Ladnyi, CFA · ex-Goldman Sachs · ex-J.P. Morgan Published 2026-04-04 Updated 2026-06-11

PEP — PepsiCo at ~$149 on ~17x forward P/E beat Q1 2026 (revenue $19.44B +8.5%, core EPS $1.61 +9% vs $1.55 consensus) with PFNA volume inflection (+2%), 54th consecutive dividend increase; FY2026 guidance maintained at 2-4% organic, management expects toward upper end in H2; GLP-1 headwind to salty snacks is the structural debate.

PEP Price Target & Rating

PEP's grade is Hold, with limited downside risk (CVaR -9.4%), and quality metrics (net margin 9%, ROE 44%). PepsiCo Inc. (PEP) trades at $144.32 with a valuation grade of Hold: a trailing P/E of 22.7x at a 5% discount to sector median, net margins of 9.1%, a DCF-implied intrinsic range of $139–$209 suggesting a +21% margin of safety, beta 0.36 (defensive risk profile).

DCF Valuation Range

Key Takeaways

Valuation: Hold grade — P/E 22.7x — DCF range $139–$209 implies +21% margin of safety
Risk: CVaR -9.4% (95th percentile, 1-month) indicates moderate tail exposure; beta of 0.36 amplifies broad market moves in both directions
Strengths: Size 4.0/5, 9% net margin, 44% ROE dominate the factor profile
Catalyst: Q2 PFNA volume turning +3%; H2 organic growth inflection toward 4%; GLP-1 demand impact data showing limited salty snack displacement
Bear catalyst: PFNA volume returns to negative; GLP-1 market share clinical study explicitly documents salty snack demand destruction; FY2026 organic growth misses 2%

PEP — Quantitative Snapshot June 2026

RatingHold

Price$144.32

Why HoldBalanced risk/reward — neither compellingly cheap nor expensive at current levels

Tail riskCVaR -9.4% over one month at the 95th percentile

DCF range$139–$209 intrinsic range; margin of safety +21%

Best useCore large-cap Consumer Defensive holding — not a source of diversified sector exposure

Next watchEarnings delivery consistency and margin trajectory

Quantitative Factor Profile

Value: 3.0 / 5
Quality: 3.0 / 5
Momentum: 3.0 / 5
Volatility: 5.0 / 5
Size: 4.0 / 5

Key Metrics

PEP Key Metrics — PepsiCo Inc. 2026
Metric	Value
Current Price	$144.32
P/E Ratio (TTM)	22.7x
Forward P/E	15.8x
PEG Ratio	0.57x
P/S Ratio	2.1
EV/EBITDA	12.8
Beta	0.36
Net Margin	9.1%
ROE	43.9%
Debt/Equity	244.8%
Dividend Yield	4.10%
CVaR (95%, 1M)	-9.4%
Market Cap	$197.3B

Analyst View

Anton Ladnyi, CFA · A.L. Capital Advisory Updated 2026-06-11

Rating Rationale

Investment Thesis

↑ Bull Case

PFNA (Frito-Lay North America) volume inflection: +2% unit growth in Q1 after prolonged weakness — the most watched metric, now turning
Core EPS +9% YoY at 17x forward P/E; 54th consecutive dividend increase; $8.9B total shareholder returns planned for FY2026
International organic growth standout (double-digit in key emerging markets); diversified geographic exposure provides resilience
Productivity savings reinvested in marketing and value positioning; H2 2026 organic growth expected toward upper end of 2-4% range

↓ Bear Case

GLP-1 drugs (Ozempic/Wegovy/Zepbound/Foundayo): structural debate about long-term salty snack demand headwind as obesity drugs proliferate; Frito-Lay is uniquely exposed
Tariff and commodity cost pass-through uncertain; supply chain disruption; aluminum packaging tariffs compressing beverage margins
Low/middle-income consumer affordability pressure — Frito-Lay's primary customer is exactly the demographic most squeezed by food/fuel inflation
At 17x forward P/E with 2-4% organic growth, limited upside vs defensive peers offering similar or better risk-adjusted returns

What Changes the Rating

↑ Catalyst: GLP-1 population study shows no measurable salty snack demand reduction; PFNA volume sustains +3%+ for two consecutive quarters

↓ Stop / exit: PFNA volume returns to negative; GLP-1 market share clinical study explicitly documents salty snack demand destruction; FY2026 organic growth misses 2%

Anton’s personal note

Hold means what it says here — I am not selling, but I am not buying either. The risk/reward at current prices is roughly balanced, and roughly balanced is not enough reason to deploy fresh capital. What I watch on this name is earnings consistency — specifically whether delivery against consensus is stable or deteriorating. That is usually where the rating gets confirmed or challenged before the price reflects it. A pullback of 10–15% from here would open the margin of safety enough that I would want to add. An earnings miss at the current multiple would do the opposite — that would be the signal to reduce rather than wait.

— Anton Ladnyi, CFA

Earnings History

PEP Earnings History — EPS Surprise Rate 2026
Quarter	EPS Est.	EPS Actual	Surprise
Q1 2026	$1.55	$1.61	+3.8% ✓
Q4 2025	$2.24	$2.26	+1.0% ✓
Q3 2025	$2.26	$2.29	+1.3% ✓
Q2 2025	$2.03	$2.12	+4.5% ✓

Quarterly EPS — Estimate vs Actual

Earnings Projections

PEP Forward EPS Consensus Estimates 2026
Quarter	EPS Est.	YoY EPS	Analysts
Q2 2026	$2.23	+5.2%	16
Q3 2026	$2.44	+6.7%	16
Q4 2026	~$2.37	+4.9%	22
Q1 2027	~$2.28	+41.6%	22
~ Estimated from annual consensus — not a direct analyst survey

Earnings Projections — Consensus EPS Estimates

PEP vs. Sector Peers

PEP Peer Valuation Comparison 2026
Ticker	P/E (TTM)	Fwd P/E	Beta	CVaR-95	Net Margin
PEP	22.7x	15.8x	0.36	-9.4%	9.1%
KO	26.3x	24.0x	0.35	-5.8%	27.8%
PG	21.8x	21.0x	0.39	-12.0%	19.2%
MCD	23.3x	19.9x	0.41	-9.8%	31.6%
COST	49.5x	43.5x	0.87	-6.6%	3.0%

DCF Scenario Analysis

Hover each scenario for detail · current price $144.32

▼

Bear Case

$114

-21.0%

Fwd P/E: 12.2x

1.0 revenue CAGR · 14.0 exit multiple

◆

Base Case

$156

+8.1%

Fwd P/E: 16.7x

4.0 revenue CAGR · 18.0 exit multiple

▲

Bull Case

$200

+38.6%

Fwd P/E: 21.5x

7.0 revenue CAGR · 22.0 exit multiple

Pairwise Correlation Matrix

0 of 10 peer pairs correlated above 0.60 — diversification benefit within this cluster is structurally limited.

Extended Analysis — Buy, Hold or Sell? Risk Factors. Portfolio Fit.

Is PEP a buy, hold, or sell?

PEP carries a valuation grade of Hold. The trailing P/E of 22.7 sits broadly in line with the Consumer Defensive sector median of 24.0x. Our discounted cash flow model produces an intrinsic range of $139–$209 — implying a +21% margin of safety at the current price of $144.32. The width of the DCF range reflects genuine uncertainty in the terminal growth rate assumption: the correct framework is a probability-weighted distribution over scenarios, not a single point estimate. See the DCF valuation framework for full methodology.

With a 12% beat rate on recent quarters, earnings predictability has been mixed. The most recent quarter delivered a 3.8% earnings surprise. Analyst estimate revisions are trending upward.

What are PEP's key risk factors?

With a beta of 0.36, PEP exhibits a low-volatility risk profile relative to the broad market. The 95th-percentile CVaR of -9.4% on a one-month horizon should inform position sizing directly: at a 10% portfolio weight, this tail event contributes approximately 0.9% of total portfolio loss in the worst 5% of months. Net margins of 9.1% fall below the Consumer Defensive sector average of 12%, suggesting margin pressure. Return on equity of 43.9% indicates highly efficient capital allocation. Debt-to-equity of 245% warrants monitoring for leverage risk.

Implied volatility of 2.6% is below realized volatility of 20.4%, potentially making options relatively cheap. Insiders have been net sellers to the tune of $13.7M recently. While routine dispositions are common, the magnitude bears watching. Short interest is low at 2.0% of float, suggesting limited bearish conviction.

How does PEP fit in a diversified portfolio?

At typical HENRY portfolio weights — 10–20% of the equity allocation — PEP carries a beta of 0.36, meaning it amplifies broad market moves proportionally. The appropriate weight is not a function of conviction alone, but of the full covariance structure across all holdings. See the Ledoit-Wolf covariance framework for the methodology behind these calculations.

Among closely correlated names, PEP shows the strongest co-movement with KO (0.55), PG (0.47), MCD (0.41). Investors seeking diversification should note these correlation dynamics when constructing multi-asset portfolios.

True portfolio risk is a function of the full covariance structure across all holdings — not individual stock metrics. The Portfolio Health Check quantifies this at the portfolio level: it surfaces hidden concentration, marginal CVaR contributions, and the degree to which your overall allocation deviates from an optimal risk-adjusted mandate. The PEP analysis here is a single node in that larger structure.

For the portfolio construction framework underpinning PEP’s position sizing and conviction rating — including IPS guardrails, Black-Litterman allocation, and CVaR constraints — see: Investment Policy Statement Framework →

Investor FAQ

Is PEP a buy or sell in 2026?

PepsiCo Inc. (PEP) carries a Hold quantitative rating from A.L. Capital Advisory, derived from Discounted Cash Flow intrinsic value analysis, five-factor model scoring (Value, Quality, Momentum, Volatility, Size), and CVaR tail risk measurement. At $144.32, the DCF midpoint margin of safety is +21% (intrinsic value range: $139 bear – $209 bull). Composite factor score: 3.6/5. Strongest factor: Volatility (5.0/5). Weakest factor: Value (3.0/5). Trailing P/E: 22.7x. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: Portfolio Construction Framework →

What is the average analyst target price for PEP?

Wall Street consensus target for PEP: $170.57 (+18.2% upside from the current price of $144.32). The analyst target range spans $132.00 (most bearish) to $195.00 (most bullish). Consensus recommendation: Hold. Note that analyst price targets typically reflect a 12-month forward horizon and are derived from a blend of DCF, comparable-company, and sum-of-the-parts analysis. A.L. Capital Advisory’s quantitative Hold rating is produced independently — from DCF intrinsic value, five-factor model scores, and CVaR tail risk — and does not mechanically track Street consensus. When the two diverge, the divergence itself is informative: it can reflect differences in time horizon, valuation methodology, or the degree to which the current price already discounts the consensus case. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: Monte Carlo Simulation Framework →

How does PEP score on Value, Quality, Momentum, Volatility, and Size?

PEP five-factor scores (A.L. Capital Advisory, 1–5 scale): Value 3.0/5 (neutral) — measures current price versus DCF intrinsic range and trailing earnings multiples; Quality 3.0/5 (neutral) — captures profitability metrics including return on equity, net margin (ROE: 43.9%) and net margin (9.1%); Momentum 3.0/5 (neutral) — reflects recent price trajectory and earnings surprise consistency; Volatility 5.0/5 (strong) — inverse measure derived from beta, where lower historical volatility earns a higher score; Size 4.0/5 (above average) — market capitalisation rank (mega-cap $1T+ scores 5/5). Composite: 3.6/5. Factor scores above 4.0 signal a tailwind in that dimension; below 2.0 signals a material headwind. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: Black-Litterman Model →

What is PEP's tail risk and CVaR?

The 95th-percentile Conditional Value at Risk (CVaR) for PEP on a one-month horizon is -9.4%. CVaR represents the expected average loss in the worst 5% of monthly outcomes — a more conservative tail risk measure than standard VaR, which only marks the loss threshold. Beta of 0.36 indicates below-market volatility. For reference, a diversified S&P 500 ETF carries a one-month CVaR of roughly -8% to -12% in normal market conditions; individual equity CVaR is higher due to idiosyncratic risk. At the portfolio level, what matters is the marginal CVaR contribution of each holding — not its standalone figure. The A.L. Capital Advisory Portfolio Health Check quantifies each position's marginal tail-risk contribution across your entire holdings. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: CVaR & Tail-Risk Methodology →

What is PEP's intrinsic value and DCF price target?

A.L. Capital Advisory's DCF model produces an intrinsic value range of $139 (bear case) to $209 (bull case) for PepsiCo Inc. (PEP). At $144.32, the midpoint margin of safety is +21% (positive = discount to intrinsic mid; negative = premium). The bear-to-bull spread reflects genuine sensitivity to the two dominant DCF inputs: the terminal growth rate and WACC. Terminal value typically accounts for 60-80% of total intrinsic value in most equity DCF models, which is why a range is more analytically sound than a point estimate. The central analytical question is not what the DCF outputs as a single number but which growth trajectory the current market price already discounts. All DCF analysis follows CFA Institute standards and is conducted by Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: DCF Valuation Framework →

What would trigger a rating upgrade or downgrade for PEP?

Upgrade trigger: A price pullback that opens the margin of safety beyond +15% (approximately $118 based on the DCF bear case). Downgrade trigger: An earnings miss at current valuations (22.7x trailing P/E) where there is limited earnings cushion to absorb negative surprises; or a sustained reversal in the Quality and Momentum factor scores for two or more consecutive quarters. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: Investment Policy Statement Framework →

Does PEP consistently beat earnings estimates?

PEP has beaten consensus EPS estimates in 12% of tracked quarterly periods — indicating inconsistent delivery. The most recent reported quarter beat consensus by 3.8%. Below-average earnings consistency is a primary headwind to the rating and a key watch item in the quantitative model. Earnings surprise magnitude and direction are incorporated into the Momentum and Quality dimensions of the five-factor scoring model. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: DCF Valuation Framework →

How does PEP contribute to portfolio risk and diversification?

PEP carries a beta of 0.36 (low-volatility / defensive relative to the broad equity market). A beta above 1.0 means the position amplifies market moves in both directions at a typical portfolio weight. Strongest peer co-movement: KO (0.55), PG (0.47), MCD (0.41). Holding PEP alongside these names in the same portfolio increases concentration risk. True portfolio risk is a function of the full covariance structure — a single stock's beta does not reveal its marginal contribution to portfolio tail loss. The A.L. Capital Advisory Portfolio Health Check quantifies concentration risk (Herfindahl-Hirschman Index), pairwise correlations, and marginal CVaR contribution across all your holdings. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: Ledoit-Wolf Covariance Framework →

What quantitative methodology does A.L. Capital Advisory use to analyse PEP?

A.L. Capital Advisory analyses PepsiCo Inc. (PEP) using a four-component quantitative framework grounded in CFA Institute standards. (1) DCF Valuation: projects free cash flows under bear and bull assumptions, discounts at WACC to produce an intrinsic value range with margin-of-safety calculation. (2) Five-Factor Scoring: each equity is scored 1–5 on Value, Quality, Momentum, Volatility, and Size. (3) CVaR Tail Risk: 95th-percentile Conditional Value at Risk from historical simulation of daily returns on a one-month horizon. (4) Earnings Surprise Analysis: quarterly beat rate and magnitude are incorporated into the Momentum and Quality factor scores. The current Hold rating for PEP is the output of applying this complete framework to current data. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: DCF Valuation Framework → · CVaR & Tail-Risk Methodology →

Stress-Test This View Live

Run PEP in Asset Lens

Live DCF valuation, Monte Carlo simulation, options flow intelligence, and full factor decomposition — updated in real time. Free, no account required.

Launch Live Analysis →

Portfolio Tool · Free

Analyse Your Full Portfolio

Upload your complete holdings and receive a quantitative risk profile — correlation structure, factor exposures, CVaR contribution by position, and overall portfolio efficiency score.

Advisory Service · €150

Portfolio Health Check

A personalised, human-delivered PDF diagnostic of your portfolio — covariance analysis, concentration risk, and a written mandate recommendation signed by Anton Ladnyi.

Valuation Framework

DCF Valuation Framework

Why terminal value drives 60–80% of equity intrinsic value — the mechanics behind P/E, EV/EBITDA, and how a 1% WACC shift moves high-multiple tech stocks ~25%.

Risk Framework

CVaR & Tail-Risk Methodology

Why variance understates downside risk in non-normal return distributions, and how Conditional Value at Risk corrects that blind spot for institutional-grade position sizing.

Allocation Framework

Black-Litterman Model

The Bayesian allocation model from Goldman Sachs — how equilibrium market returns are combined with explicit investor views to produce stable, diversified portfolios.

Market Intelligence · May 2026

Prediction Markets 2026 — The $1T Distribution Race

$51B→$1T by 2030 (Bernstein). HOOD, COIN & IBKR own the distribution moat. Full CFA-grade thesis: revenue models, regulatory risk framework, FIFA catalyst, and conviction ratings.

Market Intelligence

The $7 Trillion AI Infrastructure Race

How the $6.7T data centre build-out maps across five investor archetypes — identifying high-conviction positions in hardware, power, and infrastructure layers.

Market Intelligence

Private Equity Under Pressure

Rising rates, compressed multiples, and a backlog of exits are reshaping PE returns — where the asymmetric opportunity lies for patient capital in 2026.

Anton Ladnyi, CFA

Founder & Portfolio Architect — A.L. Capital Advisory

Ex-Goldman Sachs Equity Research · Ex-J.P. Morgan Wealth Management · CFA Charterholder

CFA Charter ↗ CFA L1 ↗ CFA L2 ↗ CFA L3 ↗ LinkedIn ↗ X ↗

Legal Disclaimer & Important Notices

This analysis is produced using a systematic quantitative framework applied to market data and does not constitute investment advice. Prose commentary is AI-assisted and generated from structured quantitative inputs. All data and metrics are as of 2026-06-11 and are point-in-time estimates subject to revision without notice. CVaR figures are based on historical simulation and do not guarantee future outcomes. DCF ranges and upgrade/downgrade triggers are forward-looking statements based on current assumptions and may not materialise. Past performance does not guarantee future results. This analysis does not account for individual circumstances, tax position, or investment objectives — consult a qualified financial advisor before making investment decisions. This content is intended for informational purposes only and does not constitute regulated investment advice under MiFID II or FCA guidelines. This content is not intended for US persons or residents of jurisdictions where its distribution would be contrary to local law or regulation. This service is not directed at residents of Finland, Sweden, Norway, Denmark, Iceland, or Poland. The author may hold long or short positions in securities mentioned in this analysis. Nothing on this page represents a solicitation to buy or sell any security. A.L. Capital Advisory is an independent private advisory practice and is not affiliated with PepsiCo Inc.